By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: FDA Has a Good Idea; Doctors Object
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > FDA Has a Good Idea; Doctors Object
BusinessNewsPublic Health

FDA Has a Good Idea; Doctors Object

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The idea: In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The Doctors’ Objection: “What the government via the FDA has decided to do is just bypass the expensive doctor and to satisfy some safety concerns of letting people just pick out their medications is make sure they have to get counsel by the pharmacists,” Dr. Mintz [an internist at George Washington University Hospital] said. “I believe there is value to using pharmacists, but not at the expense of primary care.”

The Pharmacists Counter: “We think it’s a great development for everybody — for pharmacists, for patients and the whole health care system,” said Brian Gallagher, a lobbyist for the American Pharmacists Association. “The way we look at it is there are a lot of people out there with chronic conditions that are undertreated and this would enable the pharmacists to redirect these undertreated people back into the health care system.”

More Read

The Bionic Man Makes History in Mind-Controlled Prosthetics
What Are The Different Types of IVF?
Can You Participate in a Clinical Trial?
Pediatric HCAHPS Model, First of Its Kind
State Farm Can Monitor Your Driving Habits

More from Paige Winfield Cunningham in the Washington Times.

  

TAGGED:FDApharmaceuticals
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

nurse leaders
Shaping Tomorrow’s Healthcare: The Role of Nurse Leaders
Nursing
March 10, 2026
Nursing shortage
Does Educational Rigor Negatively Impact the Talent Pool for Nursing?
Career Nursing
March 9, 2026
How Bottleless Office Water Coolers Support Corporate Sustainability Goals
eHealth Fitness Health lifestyle
March 9, 2026
public health housing
Structural Integrity in Homes and Its Impact on Public Health
Public Health
March 5, 2026

You Might also Like

4 Easy Rules for Using Numbers in Titles

July 5, 2014
ICD 10 Code Graph
BusinessFinanceHealth ReformHospital AdministrationPolicy & Law

ICD 10 Implementation: Understanding the Financial Ramifications

June 13, 2013

Video Released of TEDMED Talk on Focused Ultrasound

December 9, 2011

GAO: FDA Can’t Monitor Device Recalls

June 22, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?